A Randomized Controlled Trial Comparing the Management of Incomplete Abortion with Oral 600 mg Misoprostol with Manual Vacuum Aspiration (MVA)

被引:0
|
作者
Madhual, Niramaya [1 ]
Tiwari, Heena Dixit [2 ]
Das, Susmita [3 ]
Kamboj, Saloni [4 ]
Thakkar, Smit [5 ]
Kashif, Hala [6 ]
Mahajan, Akriti [7 ]
机构
[1] Padmini Care, Dept Obstet & Gynecol, Cuttack, Odisha, India
[2] Dist Med & Hlth Off, Visakhapatnam, Andhra Pradesh, India
[3] Aster DM Hosp, Dept Obstet & Gynecologist, Dubai, U Arab Emirates
[4] AIIMS, Dept Obstet & Gynaecol, Delhi, India
[5] Shri MP Shah Govt Med Coll, MBBS, Jamnagar, Gujarat, India
[6] Ayaan Inst Med Sci Teaching Hosp & Res Ctr, Hyderabad, Telangana, India
[7] MDS, Oral Med & Radiol, Jammu, Jammu & Kashmir, India
关键词
Abortion; conception; manual vacuum aspiration; misoprostol; pregnancy;
D O I
10.4103/jpbs.jpbs_496_23
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: In the first trimester, almost one in five identified pregnancies end in spontaneous miscarriage, and another 22% result in induced abortion. After a spontaneous and/or induced abortion, there may be retained products of conception (POC). Because of its relatively poor efficacy and the unpredictability of the time interval until spontaneous evacuation, expectant treatment is not often chosen by healthcare professionals. In view of these facts, the current study's objective was to weigh the effectiveness of MVA and oral misoprostol 600 mg in managing incomplete abortion. Materials and Procedures: The investigation was conducted at the tertiary care center in India. The survey was conducted for one year. Subjects were selected from those attending the department for either spontaneous or induced abortions. A total of 230 women were randomly assigned to receive the interventions of a single dose of oral misoprostol 600 mcg or MVA. They were equally distributed to two groups and observed for the various parameters of success, signs and symptoms, satisfaction, and complications. The obtained values were compared statistically for the significance at <0.05 of P values. Results: Of the 200 subjects (30 lost to follow-up), there was no significant variance in the demographics, clinical outcomes, and complications between the groups. However, the pain, fever, shivering, and satisfaction parameters were statistically variant between the groups. Fever, shivering, and pain were lower for the MISO subjects while satisfaction was reported higher from subjects in MISO group. Conclusion: MISO and MVA are acceptable, safe, and efficient therapies for first-trimester un-complicated incomplete abortion. Nonetheless, misoprostol appears to be a marginally superior option to MVA in terms of accessibility, low therapy costs, reduced pain, and reduced demand for specialized personnel or equipment.
引用
收藏
页码:S290 / S292
页数:3
相关论文
共 50 条
  • [31] Intrauterine adhesion in ultrasound-guided manual vacuum aspiration (USG-MVA) versus electric vacuum aspiration (EVA): a randomised controlled trial
    Chung, Jacqueline Pui Wah
    Law, Tracy Sze Man
    Ng, Karen
    Ip, Patricia Nga Ping
    Li, Tin Chiu
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [32] Mifepristone and Oral, Vaginal, or Sublingual Misoprostol for Second-Trimester Abortion A Randomized Controlled Trial
    Dickinson, Jan E.
    Jennings, Belinda G.
    Doherty, Dorota A.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 (06): : 1162 - 1168
  • [33] A comparative study of cost of care and duration of management for first-trimester abortion with manual vacuum aspiration (MVA) and sharp curettage
    Thanapan Choobun
    Siwatchaya Khanuengkitkong
    Sutham Pinjaroen
    Archives of Gynecology and Obstetrics, 2012, 286 : 1161 - 1164
  • [34] A comparative study of cost of care and duration of management for first-trimester abortion with manual vacuum aspiration (MVA) and sharp curettage
    Choobun, Thanapan
    Khanuengkitkong, Siwatchaya
    Pinjaroen, Sutham
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (05) : 1161 - 1164
  • [35] 25 mg or 50 mg of oral methotrexate followed by vaginal misoprostol 7 days after for early abortion -: A randomized trial
    Esteve, JLC
    Varela, L
    Velazco, A
    Tanda, R
    Sánchez, C
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 47 (03) : 182 - 187
  • [36] A randomised controlled trial comparing oral and vaginal misoprostol administered one hour before surgical abortion.
    Sharma, S
    El Refaey, H
    Stafford, M
    Purkayastha, S
    Parry, M
    Axby, H
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 158A - 158A
  • [37] A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy
    Chatawan Saichua
    Vorapong Phupong
    Archives of Gynecology and Obstetrics, 2009, 280 : 431 - 435
  • [38] A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy
    Saichua, Chatawan
    Phupong, Vorapong
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (03) : 431 - 435
  • [39] A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain
    Salo, DF
    Lavery, R
    Varma, V
    Goldberg, J
    Shapiro, T
    Kenwood, A
    ACADEMIC EMERGENCY MEDICINE, 2003, 10 (01) : 22 - 30
  • [40] Comparison of oral and vaginal misoprostol for cervical ripening before manual vacuum aspiration of first trimester pregnancy under local anesthesia: a randomized placebo-controlled study
    Cakir, L
    Dilbaz, B
    Caliskan, E
    Dede, FS
    Dilbaz, S
    Haberal, A
    CONTRACEPTION, 2005, 71 (05) : 337 - 342